Saturday, October 31, 2026

Single-Port Robotic Surgery Shows Strong Results for Upper Tract Urothelial Cancer, Cuts Operating Time by 52 Minutes

A Seoul St. Mary’s Hospital study found that single-port robotic retroperitoneal surgery for upper tract urothelial cancer shortened operating time by 23.5%, reduced blood loss and showed comparable oncologic safety to conventional multi-port surgery.

LA Dodgers’ Shohei Ohtani Snags Million Dollar Mansion Near Dodgers Stadium

Major League Baseball (MLB) superstar Shohei Ohtani...

GCCell Secures Groundbreaking Patent for Next-Gen Cell Therapy: What It Means for the Future of Immunotherapy

GC Cell has completed the registration of core technology patents for next-gen cell and gene therapies in South Korea and Japan.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.

How Huons Global is Transforming the Middle East Aesthetic Market with Innovative Products

Huons Group targets the Middle East market by consolidating its aesthetic products, including fillers and botulinum toxin.

Wontech Partners With China’s Yestar to Expand Medical Aesthetics Push

Wontech is partnering with Chinese medical aesthetics group Yestar to expand physician training, clinical collaboration and adoption of its NMPA-approved laser devices in China.

Vuno to Discuss AI for Pediatric Patient Safety at Global Symposium

Vuno will bring domestic and international experts together in Seoul to discuss AI-based early warning and rapid response systems for improving pediatric patient safety.

GC Pharma Wins Approval for Phase 2 Trial of COVID-19 mRNA Vaccine

GC Pharma has received approval for a Phase 2 trial of its COVID-19 mRNA vaccine candidate GC4006A and plans to advance toward Phase 3 while expanding the platform into other disease areas.

RF Bio Earns International Occupational Safety Certification, Strengthening Manufacturing Competitiveness

RF Bio has earned ISO 45001 certification as it strengthens workplace safety and manufacturing quality while expanding its medical aesthetics business globally.

SK Biopharm’s Epilepsy Drug Trial Partially Halted in U.S., New Enrollment Suspended

SK Biopharm's U.S. trials of epilepsy drug candidate opicopalim have been partially placed on hold by the FDA, temporarily stopping new enrollment while existing patients continue treatment.

Korean Doctor Wins Top U.S. ENT Research Award, Paving New Path for Sinusitis Treatment

Kyung Hee University professor Min Jin-young won a prestigious U.S. otolaryngology research award for identifying a new sinusitis mechanism and developing a potential low-cost, personalized treatment strategy.

Korean Obesity Drug Set to Launch Next Month as Hanmi’s Efe Targets Market

Hanmi Pharmaceutical plans to launch its domestically developed GLP-1 obesity drug Efe as early as next month, with Korean clinical data, safety and domestic production as key selling points.

Handok Positions Sleep Care as New Growth Driver, Linking Diagnosis, Treatment and Management

Handok is positioning sleep as a new digital health care growth driver by connecting diagnosis, treatment and everyday management through technologies such as digital therapeutics and AI-based sleep monitoring.

How AmorePacific’s New Microbiome Extract Could Revolutionize Acne Scar Treatment

Amorepacific confirms its proprietary microbiome strain extract may help improve post-acne pigmentation and inflammation.

Top 5 Promising Lung Cancer Treatments Revealed at WCLC 2026: What You Need to Know

The world's largest conference on lung cancer will be held in Seoul after 19 years, showcasing clinical results from local pharmaceutical firms.

Why the ArtiSential PRO is a Game Changer for Surgeons: 5 Key Features Explained

LIVSMED is expanding its surgical device portfolio, focusing on its flagship product, the multi-joint laparoscopic instrument ArtiSential PRO.

How COLO eDX is Changing Colon Cancer Monitoring: Key Insights from iCRS 2026

Gencurix confirms its blood-based colon cancer test can detect cancer and monitor recurrence post-surgery.

GCCL Expands Global Partnerships at ABP 2026: Insights into Asia-Pacific Biotech Growth

GCCL, a global clinical trial specimen analysis firm, expanded its collaboration at the Asia Bio Partnering Forum 2026 in Singapore.

Top News

- Our Sponsors Ad -

Follow us